| 1 |
33864822 | Carboxylesterases and arylacetamide deacetylase comparison in human A549, H460, and H727 pulmonary cells. | 2021 Jul 15 |
1 |
| 2 |
29407485 | Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung. | 2018 Apr |
1 |
| 3 |
28126414 | Recent progress in the discovery of natural inhibitors against human carboxylesterases. | 2017 Mar |
1 |
| 4 |
29054529 | Development of amide-based fluorescent probes for selective measurement of carboxylesterase 1 activity in tissue extracts. | 2017 Dec 15 |
1 |
| 5 |
26825642 | Age-Dependent Human Hepatic Carboxylesterase 1 (CES1) and Carboxylesterase 2 (CES2) Postnatal Ontogeny. | 2016 Jul |
2 |
| 6 |
26900660 | Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2. | 2016 Apr 13 |
1 |
| 7 |
25346527 | Synthetic cannabimimetic agents metabolized by carboxylesterases. | 2015 Jul |
3 |
| 8 |
25462813 | Efficient in vitro refolding and functional characterization of recombinant human liver carboxylesterase (CES1) expressed in E. coli. | 2015 Mar |
2 |
| 9 |
24988246 | The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect. | 2014 |
2 |
| 10 |
23386599 | The role of human carboxylesterases in drug metabolism: have we overlooked their importance? | 2013 Feb |
1 |
| 11 |
23386702 | Reversible inhibition of human carboxylesterases by acyl glucuronides. | 2013 Apr |
1 |
| 12 |
23647544 | Investigation binding patterns of human carboxylesterase I (hCES I) with broad substrates by MD simulations. | 2013 |
1 |
| 13 |
22100607 | Inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by chlorpyrifos oxon, paraoxon and methyl paraoxon. | 2012 Jan 1 |
1 |
| 14 |
21918037 | Characterization of the expression and activity of carboxylesterases 1 and 2 from the beagle dog, cynomolgus monkey, and human. | 2011 Dec |
1 |
| 15 |
18983829 | Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin. | 2009 Jan 15 |
1 |
| 16 |
18305428 | Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs. | 2008 Feb 18 |
1 |
| 17 |
15908471 | Identification of esterases expressed in Caco-2 cells and effects of their hydrolyzing activity in predicting human intestinal absorption. | 2005 Aug |
1 |
| 18 |
8496932 | Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 2. Modification of fatty acid anilide ACAT inhibitors: bioisosteric replacement of the amide bond. | 1993 May 28 |
4 |